Cargando…

Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex

The androgen receptor (AR) pathway regulates key cell survival programs in prostate epithelium. The AR represents a near-universal driver and therapeutic vulnerability in metastatic prostate cancer, and targeting AR has a remarkable therapeutic index. Though most approaches directed toward AR focus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nyquist, Michael D., Coleman, Ilsa M., Lucas, Jared M., Li, Dapei, Hanratty, Brian, Meade, Hannah, Mostaghel, Elahe A., Plymate, Stephen R., Corey, Eva, Haffner, Michael C., Nelson, Peter S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2023
Materias:	Translational Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472100/ https://www.ncbi.nlm.nih.gov/pubmed/37352376 http://dx.doi.org/10.1158/0008-5472.CAN-22-2613

Ejemplares similares

Supraphysiologic Testosterone Therapy in the Treatment of Prostate Cancer: Models, Mechanisms and Questions
por: Mohammad, Osama S., et al.
Publicado: (2017)

Response to supraphysiological testosterone is predicted by a distinct androgen receptor cistrome
por: Qiu, Xintao, et al.
Publicado: (2022)

Statins and adrenal androgen levels in prostate cancer: A new twist
por: Mostaghel, Elahe A
Publicado: (2021)

Beyond T and DHT - Novel Steroid Derivatives Capable of Wild Type Androgen Receptor Activation
por: Mostaghel, Elahe A
Publicado: (2014)

Temporal Requirements of cMyc Protein for Reprogramming Mouse Fibroblasts
por: Heffernan, Corey, et al.
Publicado: (2012)

Therapeutic Implications for Intrinsic Phenotype Classification of Metastatic Castration-Resistant Prostate Cancer
por: Coleman, Ilsa M., et al.
Publicado: (2022)

Prostate Cancer Characteristics Associated with Response to Pre-Receptor Targeting of the Androgen Axis
por: Mostaghel, Elahe A., et al.
Publicado: (2014)

Circulating and Intratumoral Adrenal Androgens Correlate with Response to Abiraterone in Men with Castration-Resistant Prostate Cancer
por: Mostaghel, Elahe A., et al.
Publicado: (2021)

A proteomic study of cMyc improvement of CHO culture
por: Kuystermans, Darrin, et al.
Publicado: (2010)

Effects of Exogenous Androgens on Platelet Activity and Their Thrombogenic Potential in Supraphysiological Administration: A Literature Review
por: Roşca, Adrian Eugen, et al.
Publicado: (2021)

Impact of Circulating Cholesterol Levels on Growth and Intratumoral Androgen Concentration of Prostate Tumors
por: Mostaghel, Elahe A., et al.
Publicado: (2012)

Androgen Receptor Promotes Ligand-Independent Prostate Cancer Progression through c-Myc Upregulation
por: Gao, Lina, et al.
Publicado: (2013)

Resistance to androgen receptor signaling inhibition does not necessitate development of neuroendocrine prostate cancer
por: Brennen, W. Nathaniel, et al.
Publicado: (2021)

Supraphysiological androgen levels induce cellular senescence in human prostate cancer cells through the Src-Akt pathway
por: Roediger, Julia, et al.
Publicado: (2014)

Supraphysiological doses of performance enhancing anabolic-androgenic steroids exert direct toxic effects on neuron-like cells
por: Basile, John R., et al.
Publicado: (2013)

Intracrine androgen biosynthesis and drug resistance
por: Penning, Trevor M., et al.
Publicado: (2020)

Loss of MYSM1 inhibits the oncogenic activity of cMYC in B cell lymphoma
por: Lin, Yun Hsiao, et al.
Publicado: (2021)

Identification of Androgen Receptor Metabolic Correlome Reveals the Repression of Ceramide Kinase by Androgens
por: Camacho, Laura, et al.
Publicado: (2021)

Transformation of normal cells by aberrant activation of YAP via cMyc with TEAD
por: Nishimoto, Masazumi, et al.
Publicado: (2019)

Sex differences in the effects of androgens acting in the central nervous system on metabolism
por: Morford, Jamie, et al.
Publicado: (2016)

Harnessing Solute Carrier Transporters for Precision Oncology
por: Nyquist, Michael D., et al.
Publicado: (2017)

Androgen receptor activity in prostate cancer dictates efficacy of bipolar androgen therapy through MYC
por: Sena, Laura A., et al.
Publicado: (2022)

The androgen receptor mediates antiapoptotic function in myometrial cells
por: Li, H, et al.
Publicado: (2014)

SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of cMYC oncoprotein
por: Geng, Chuandong, et al.
Publicado: (2017)

Tzfp Represses the Androgen Receptor in Mouse Testis
por: Furu, Kari, et al.
Publicado: (2013)

Transition from cMyc to L-Myc during dendritic cell development coordinated by rising levels of IRF8
por: Anderson, David A., et al.
Publicado: (2021)

The scaffold protein menin is essential for activating the MYC locus and MYC‐mediated androgen receptor transcription in androgen receptor‐dependent prostate cancer cells
por: Luo, Yakun, et al.
Publicado: (2021)

Gefitinib treatment affects androgen levels in non-small-cell lung cancer patients
por: Nishio, M, et al.
Publicado: (2005)

Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancer
por: Henzler, Christine, et al.
Publicado: (2016)

Androgen receptor splice variants activating the full-length receptor in mediating resistance to androgen-directed therapy
por: Cao, Bo, et al.
Publicado: (2014)

Convergence of cMyc and β‐catenin on Tcf7l1 enables endoderm specification
por: Morrison, Gillian, et al.
Publicado: (2015)

cMYC expression in thyroid follicular cell-derived carcinomas: a role in thyroid tumorigenesis
por: Sakr, Hany I., et al.
Publicado: (2017)

Elevated Nuclear PHGDH Synergistically Functions with cMyc to Reshape the Immune Microenvironment of Liver Cancer
por: Zhu, Hongwen, et al.
Publicado: (2023)

Repressive Effects of Resveratrol on Androgen Receptor Transcriptional Activity
por: Shi, Wen-feng, et al.
Publicado: (2009)

AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development
por: Takizawa, Makiko, et al.
Publicado: (2008)

c-MYC-Induced AP4 Attenuates DREAM-Mediated Repression by p53
por: Kaller, Markus, et al.
Publicado: (2023)

Androgen receptor and MYC equilibration centralizes on developmental super-enhancer
por: Guo, Haiyang, et al.
Publicado: (2021)

Enhanced killing of androgen-independent prostate cancer cells using inositol hexakisphosphate in combination with proteasome inhibitors
por: Diallo, J-S, et al.
Publicado: (2008)

Pharmacological Targeting of Androgen Receptor Elicits Context-Specific Effects in Estrogen Receptor–Positive Breast Cancer
por: Wei, Lixuan, et al.
Publicado: (2023)

Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer
por: Sowalsky, Adam G., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9scq5af6922dde8knf39g3keii